Neurizon Therapeutics Reports Positive NUZ-001 Study
Neurizon Therapeutics (ASX: NUZ) has announced encouraging outcomes from an independent study assessing its neuroprotective ...
The Australian13d
Long Shortz with Neurizon Therapeutics: Clinical hold lift on the horizon
Watch the video to see the initiatives Neurizon is taking. This video was developed in collaboration with Neurizon ...
Stockhead on MSN1d
StockTake: Neurizon’s potential cure for Alzheimer’s
NUZ-001 has shown it promotes healthy and viable brain tissues, potentially demonstrating its use to treat Alzheimer’s and ...
HotCopper on MSN1d
Neurizon finds positive results for lead drug in 3D brain model study
Neurizon Therapeutics Ltd (ASX:NUZ) has yielded positive results from an independent study – conducted in collaboration with ...
Break it Down: One step closer to treating ALS
Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds. In this episode, Tylah Tully gives the ...
Stockhead on MSN1d
Health Check: It’s a CEO changing of the guard at Mach 7 and Universal Biosensors
Mach 7 and Universal Biosensors have announced their CEOs will depart, while changes at the top are likely at other biotechs.
Geelong Advertiser12d
Long Shortz with Neurizon Therapeutics: Clinical hold lift on the horizon
Neurizon Therapeutics plans to implement several initiatives to get the clinical hold lifted of its IND application for NUZ-001. The company has been in discussion with the US FDA since February ...